Peter Häusler

1.0k total citations
14 papers, 820 citations indexed

About

Peter Häusler is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Peter Häusler has authored 14 papers receiving a total of 820 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 4 papers in Molecular Biology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Peter Häusler's work include Colorectal Cancer Treatments and Studies (9 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Genetic factors in colorectal cancer (3 papers). Peter Häusler is often cited by papers focused on Colorectal Cancer Treatments and Studies (9 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Genetic factors in colorectal cancer (3 papers). Peter Häusler collaborates with scholars based in Germany, Italy and Netherlands. Peter Häusler's co-authors include Wolfgang Schwabe, Detlev Behnke, André B. P. Kuilenburg, Adriana Eramo, Giovina Ruberti, Giuliana Papoff, Martin Kristian Raida, A. H. van Gennip, K. Höffken and Alberto Signore and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and European Journal of Immunology.

In The Last Decade

Peter Häusler

14 papers receiving 801 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Häusler Germany 10 527 352 139 132 128 14 820
Yuichi Yakata Japan 11 467 0.9× 267 0.8× 156 1.1× 109 0.8× 91 0.7× 14 727
Luis T. Campos United States 13 441 0.8× 201 0.6× 114 0.8× 74 0.6× 145 1.1× 29 726
Akio Saiura Japan 12 409 0.8× 258 0.7× 64 0.5× 231 1.8× 125 1.0× 38 766
M Ikeguchi Japan 18 410 0.8× 377 1.1× 81 0.6× 319 2.4× 321 2.5× 55 1.0k
M Volm Germany 13 459 0.9× 293 0.8× 44 0.3× 50 0.4× 126 1.0× 42 749
Etsuji Shimada Japan 9 236 0.4× 184 0.5× 61 0.4× 109 0.8× 70 0.5× 24 457
Massimo Zeuli Italy 14 546 1.0× 226 0.6× 87 0.6× 159 1.2× 276 2.2× 37 917
Fernanda Fabiani Italy 11 182 0.3× 525 1.5× 107 0.8× 96 0.7× 154 1.2× 21 731
Woo Sun Kwon South Korea 16 401 0.8× 267 0.8× 56 0.4× 89 0.7× 271 2.1× 51 677
Genevieve A. Andrews United States 9 284 0.5× 212 0.6× 93 0.7× 84 0.6× 87 0.7× 14 492

Countries citing papers authored by Peter Häusler

Since Specialization
Citations

This map shows the geographic impact of Peter Häusler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Häusler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Häusler more than expected).

Fields of papers citing papers by Peter Häusler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Häusler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Häusler. The network helps show where Peter Häusler may publish in the future.

Co-authorship network of co-authors of Peter Häusler

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Häusler. A scholar is included among the top collaborators of Peter Häusler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Häusler. Peter Häusler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Kuilenburg, André B. P., Peter Häusler, Andreas Schalhorn, et al.. (2012). Evaluation of 5-Fluorouracil Pharmacokinetics in Cancer Patients with a C.1905+1G>A Mutation in DPYD by Means of a Bayesian Limited Sampling Strategy. Clinical Pharmacokinetics. 51(3). 163–174. 62 indexed citations
2.
Kuilenburg, André B. P., Peter Häusler, Andreas Schalhorn, et al.. (2011). Evaluation of 5-FU pharmacokinetics in cancer patients with DPD deficiency using a Bayesian limited sampling strategy. Data Archiving and Networked Services (DANS). 33(4). 1 indexed citations
3.
Kuilenburg, André B. P., Jan Gerard Maring, Andreas Schalhorn, et al.. (2008). Pharmacokinetics of 5-Fluorouracil in Patients Heterozygous for the IVS14+1G > A Mutation in the Dihydropyrimidine Dehydrogenase Gene. Nucleosides Nucleotides & Nucleic Acids. 27(6-7). 692–698. 22 indexed citations
5.
Liersch, Torsten, Claus Langer, B. Michael Ghadimi, et al.. (2006). Lymph Node Status and TS Gene Expression Are Prognostic Markers in Stage II/III Rectal Cancer After Neoadjuvant Fluorouracil-Based Chemoradiotherapy. Journal of Clinical Oncology. 24(25). 4062–4068. 66 indexed citations
6.
Jakob, Christiane, Torsten Liersch, W. Meyer, et al.. (2005). Immunohistochemical Analysis of Thymidylate Synthase, Thymidine Phosphorylase, and Dihydropyrimidine Dehydrogenase in Rectal Cancer (cUICC II/III). The American Journal of Surgical Pathology. 29(10). 1304–1309. 28 indexed citations
7.
8.
Kornmann, Marko, Wolfgang Schwabe, Silvia Sander, et al.. (2003). Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression levels: predictors for survival in colorectal cancer patients receiving adjuvant 5-fluorouracil.. PubMed. 9(11). 4116–24. 136 indexed citations
9.
Raida, Martin Kristian, Wolfgang Schwabe, Peter Häusler, et al.. (2001). Prevalence of a common point mutation in the dihydropyrimidine dehydrogenase (DPD) gene within the 5'-splice donor site of intron 14 in patients with severe 5-fluorouracil (5-FU)- related toxicity compared with controls.. PubMed. 7(9). 2832–9. 188 indexed citations
10.
Potolicchio, Ilaria, et al.. (1999). HLA-DP molecules bind cobalt: a possible explanation for the genetic association with hard metal disease. European Journal of Immunology. 29(7). 2140–2147. 37 indexed citations
11.
Papoff, Giuliana, et al.. (1999). Identification and Characterization of a Ligand-independent Oligomerization Domain in the Extracellular Region of the CD95 Death Receptor. Journal of Biological Chemistry. 274(53). 38241–38250. 125 indexed citations
12.
Potolicchio, Ilaria, et al.. (1999). HLA-DP molecules bind cobalt: a possible explanation for the genetic association with hard metal disease. European Journal of Immunology. 29(7). 2140–2147. 4 indexed citations
13.
Häusler, Peter, Giuliana Papoff, Adriana Eramo, et al.. (1998). Protection of CD95-mediated apoptosis by activation of phosphatidylinositide 3-kinase and protein kinase B. European Journal of Immunology. 28(1). 57–69. 98 indexed citations
14.
Burián, Katalin & Peter Häusler. (1953). [Studies of circulation dynamics in Meniere's disease].. PubMed. 32(2). 94–9. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026